| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Global Operations And R&D | EVP, Global Manufacturing
2 companies
Helsel Dave is a SVP Global Operations And R&D at ANGO, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $823K at current prices.
Our model assigns Helsel Dave a strong insider score of 71/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +47.1%.
Helsel Dave's largest disclosed position is in HAE as EVP, Global Manufacturing, worth about $578K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | ANGO Angiodynamics Inc | SVP Global Operations And R&D | Sell | 4,633 | $12.95 | $59,997.35 | -19.4% | -33.9% | -54.7% | |
| Jul 29, 2022 | ANGO Angiodynamics Inc | SVP Global Operations And R&D | Sell | 5,000 | $22.44 | $112,200.00 | -17.3% | -41.3% | -61.9% | |
| Apr 28, 2022 | ANGO Angiodynamics Inc | SVP Global Operations And R&D | Sell | 3,513 | $22.44 | $78,831.72 | -13.3% | +0.6% | -63.0% | |
| Oct 20, 2021 | ANGO Angiodynamics Inc | SVP Global Operations And R&D | Sell | 3,494 | $27.97 | $97,727.18 | -11.7% | -20.6% | -52.2% | |
| Apr 14, 2021 | ANGO Angiodynamics Inc | SVP Global Operations And R&D | Sell | 3,500 | $23.93 | $83,755.00 | -15.5% | +15.0% | -4.0% |